Zura Bio Announces Oversubscribed $112.5 Million Private Placement
Zura Bio Announces Robert Lisicki as CEO and Director
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
Zura Bio Announces Participation at March Conferences
Zura Bio Announces Participation at February Investor Conferences
Zura Bio Continues to Strengthen Leadership
Zura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Zura Bio Announces Two Immunology Abstracts Presented
Zura Bio Appoints Arnout Ploos van Amstel to its Board of Directors
Zura Bio Reports Third Quarter 2023 Financial Results